Sign in
Taking peopleNo phase

Body, fitness and lifestyle factors linked to low testosterone in middle-aged men

Looks at what relates to testosterone levels in men from the general population.

Key facts

Who runs it
Andijan State Medical Institute
Where
Uzbekistan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged Men
Status
Recruiting
People taking part
600 people, planned
Started
1 Jun 2026
Expected to end
31 Dec 2027
Type of study
Observational, 2 groups
Treatments tested
  • Observational Assessment
Record updated
25 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for men aged 35-59 years who live permanently in the Andijan region of Uzbekistan. It studies body size, physical function and lifestyle factors linked to testosterone levels.

Age
35 to 59 years
Sex
Men only
Earlier treatment
People already using testosterone, or other medicines known to strongly affect male hormones, cannot join.

Main reasons for not taking part

  • Hypogonadism (low male hormone condition) already diagnosed and needing testosterone replacement therapy
  • Current use of testosterone or medicines that strongly affect male hormones
  • Severe heart, liver or kidney disease that the body can no longer compensate for
  • Significant urinary tract or male genital problems, or a sudden infection or inflammation at the time of the tests
  • Severe mental illness or memory and thinking problems that limit taking part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Men aged 35-59 years
  • Permanent residence in the Andijan region of Uzbekistan
  • Ability and willingness to provide written informed consent
  • Willingness to undergo clinical, anthropometric, functional and laboratory assessments

Who cannot take part

  • Previously diagnosed hypogonadism requiring testosterone replacement therapy
  • Current use of testosterone preparations or other medications known to substantially affect androgen status
  • Severe cardiovascular, hepatic or renal disease in the stage of decompensation
  • Severe psychiatric illness or cognitive impairment limiting study participation
  • Acute infectious or inflammatory conditions at the time of assessment
  • Clinically significant urological pathology

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 35 and 59 years old?

This trial is currently available in Uzbekistan.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Decreased testosterone levels in middle-aged men are associated with multiple metabolic, functional and psychosocial consequences. Early identification of modifiable factors associated with reduced testosterone levels may facilitate the early identification of men at increased risk of testosterone deficiency and support preventive healthcare strategies.

Read full original descriptionShow less

This population-based cross-sectional observational study aims to investigate anthropometric, functional and lifestyle-related factors associated with serum total testosterone levels in middle-aged men. Approximately 600 men aged 35-59 years residing in the Andijan region of Uzbekistan will be recruited.

Participants will undergo comprehensive assessment including anthropometric measurements, functional performance tests, standardised questionnaires and laboratory determination of serum total testosterone concentrations. Anthropometric variables will include body mass index, waist circumference, hip circumference, waist-to-hip ratio and waist-to-height ratio. Functional status will be assessed using hand-grip strength, the five-times chair-stand test and the 4-m walk test. Lifestyle-related factors will be assessed using standardised and study-specific questionnaires. Physical activity will be assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF), while dietary habits, sleep characteristics, smoking status, alcohol consumption and psychosocial characteristics will be assessed using a structured study questionnaire.

The study aims to identify factors associated with serum total testosterone levels and to develop a predictive model for the early identification of men at increased risk of testosterone deficiency.

The 2 groups in the trial

  • Men with Normal Testosterone Levels

    Participants classified after baseline laboratory assessment as having serum total testosterone concentrations within the laboratory reference range.

    Treatment: Observational Assessment

  • Men with Decreased Testosterone Levels

    Participants classified after baseline laboratory assessment as having decreased serum total testosterone concentrations according to predefined laboratory reference criteria.

    Treatment: Observational Assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Anthropometric, Functional and Lifestyle-related Factors Associated With Testosterone Levels Among Middle-aged Men in Uzbekistan: Protocol for a Population-based Cross-sectional Study
Plain-language title
Body, fitness and lifestyle factors linked to low testosterone in middle-aged menGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07476222, who can take part
Publications
Record updated
25 August 2026